Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-12-13 00:00:00 ET · period of report 2022-12-09 · accession 0001415889-22-012508 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-13 | 2022-12-09+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +14.0K | 5,929 | New | +$29.9K |
| DM | 2022-12-13 | 2022-12-09+ | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $28.43 | -14.0K | 1,960 | -88% | -$397.2K |
| DM | 2022-12-13 | 2022-12-09+ | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $0.00 | -14.0K | 79.9K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-12 | M | A | 10,000 | $2.14 | 11,960 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-12 | S | D | 10,000 | $30.04 | 1,960 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.39, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2022-12-09 | S | D | 3,386 | $24.23 | 2,543 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $25.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2022-12-09 | M | A | 3,969 | $2.14 | 5,929 | D | — | — | |
| 5 | Common | Common Stock | 2022-12-09 | S | D | 583 | $25.23 | 1,960 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.01 to $25.41, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-12-09 | M | D | 3,969 | $0.00 | 36,757 | D | $2.14 · — to 2031-04-01 | 3,969 Common Stock | (F5) A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 7 | Derivative | Stock Option (Right to Buy) | 2022-12-12 | M | D | 7,094 | $0.00 | 29,663 | D | $2.14 · — to 2031-04-01 | 7,094 Common Stock | (F5) A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |
| 8 | Derivative | Stock Option (Right to Buy) | 2022-12-12 | M | D | 2,906 | $0.00 | 79,863 | D | $2.14 · — to 2031-04-01 | 2,906 Common Stock | (F6) A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |